Endocrine therapy in the management of low-grade serous ovarian/peritoneal carcinoma: Mounting evidence for therelative efficacy of tamoxifen and aromatase inhibitors

David M. Gershenson; Lauren P. Cobb; Charlotte C. Sun

doi:10.1016/j.ygyno.2020.09.049

Endocrine therapy in the management of low-grade serous ovarian/peritoneal carcinoma: Mounting evidence for therelative efficacy of tamoxifen and aromatase inhibitors

David M. Gershenson, Lauren P. Cobb, Charlotte C. Sun

Gynecological Oncology & Reproductive Medicine

Research output: Contribution to journal › Editorial › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	601-603
Number of pages	3
Journal	Gynecologic oncology
Volume	159
Issue number	3
DOIs	https://doi.org/10.1016/j.ygyno.2020.09.049
State	Published - Dec 2020

ASJC Scopus subject areas

Oncology
Obstetrics and Gynecology

Access to Document

10.1016/j.ygyno.2020.09.049

Cite this

@article{36e3bd6f3a834f788aa9cd19dc33a69c,

title = "Endocrine therapy in the management of low-grade serous ovarian/peritoneal carcinoma: Mounting evidence for therelative efficacy of tamoxifen and aromatase inhibitors",

author = "Gershenson, {David M.} and Cobb, {Lauren P.} and Sun, {Charlotte C.}",

note = "Funding Information: This work was supported in part by the MD Anderson Cancer Center Ovarian Moonshot and the MD Anderson Cancer Center Support Grant from the National Cancer Institute (NIH/NCI P30 CA016672 , CA217685 ). Funding Information: This work was supported in part by the MD Anderson Cancer Center Ovarian Moonshot and the MD Anderson Cancer Center Support Grant from the National Cancer Institute (NIH/NCI P30 CA016672, CA217685). Funding Information: This work was supported in part by the MD Anderson Cancer Center Ovarian Moonshot and the MD Anderson Cancer Center Support Grant from the National Cancer Institute (NIH/NCI P30 CA016672, CA217685).",

year = "2020",

month = dec,

doi = "10.1016/j.ygyno.2020.09.049",

language = "English (US)",

volume = "159",

pages = "601--603",

journal = "Gynecologic oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

number = "3",

}

TY - JOUR

T1 - Endocrine therapy in the management of low-grade serous ovarian/peritoneal carcinoma

T2 - Mounting evidence for therelative efficacy of tamoxifen and aromatase inhibitors

AU - Gershenson, David M.

AU - Cobb, Lauren P.

AU - Sun, Charlotte C.

N1 - Funding Information: This work was supported in part by the MD Anderson Cancer Center Ovarian Moonshot and the MD Anderson Cancer Center Support Grant from the National Cancer Institute (NIH/NCI P30 CA016672 , CA217685 ). Funding Information: This work was supported in part by the MD Anderson Cancer Center Ovarian Moonshot and the MD Anderson Cancer Center Support Grant from the National Cancer Institute (NIH/NCI P30 CA016672, CA217685). Funding Information: This work was supported in part by the MD Anderson Cancer Center Ovarian Moonshot and the MD Anderson Cancer Center Support Grant from the National Cancer Institute (NIH/NCI P30 CA016672, CA217685).

PY - 2020/12

Y1 - 2020/12

UR - http://www.scopus.com/inward/record.url?scp=85091938038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091938038&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2020.09.049

DO - 10.1016/j.ygyno.2020.09.049

M3 - Editorial

C2 - 33019983

AN - SCOPUS:85091938038

SN - 0090-8258

VL - 159

SP - 601

EP - 603

JO - Gynecologic oncology

JF - Gynecologic oncology

IS - 3

ER -

Endocrine therapy in the management of low-grade serous ovarian/peritoneal carcinoma: Mounting evidence for therelative efficacy of tamoxifen and aromatase inhibitors

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this